What is Wegovy?
WEGOVY® (semaglutide) injection is an injectable prescription medicine used with a reduced calorie diet and increased physical activity:
- to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® is safe and effective for use in children under 12 years of age.
Wegovy® dosing schedule
The starting dose of Wegovy® is 0.25 mg once weekly, and you will gradually increase your dose every 4 weeks until you reach your maintenance dose of either 1.7 mg or 2.4 mg. Work with your health care professional to determine which dose is right for you.
|
Weeks 1-4 |
Weeks 5-8 |
Weeks 9-12 |
Weeks 13-16 |
Week 17+ |
|---|---|---|---|---|
| Start Wegovy® at a dose of 0.25 mg per week for your first four weeks | For weeks five through eight, you’ll increase your weekly dose to 0.5 mg | For weeks nine through twelve, you’ll increase your weekly dose to 1 mg | For weeks thirteen through sixteen, you’ll increase your weekly dose to 1.7 mg | From week seventeen onward, your health care professional may have you stay at 1.7 mg or increase to 2.4 mg. The maximum dose of Wegovy® is 2.4 mg |
Reviews
There are no reviews yet.